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patients with no PPM versus 46±8 mmHg and 68% in patients with PPM (p<0.001). Con-
clusions: PPM is associated with persisting PA hypertension after MVR. The clinical
implications of these results are important given that PPM is frequent in patients under-
going MVR and could largely be avoided by using a prospective strategy at the time of
operation. 
1048-138 Edge-to-Edge Mitral Repair Seems to Induce Functional 
Restriction
Catherine Sportouch, Valérie Rauzy, Philippe Rouvière, Franck Raczka, Jean-Marc 
Frapier, Jean-Marc Davy, Bernard Albat, Hopital Arnaud de Villeneuve, Montpellier, 
France
Objective: Edge-to-edge mitral repair could be a limiting factor for exercise tolerance due
to increasing transmitral gradient during stress test.
Methods: Between June 2000 and December 2002, 28 patients with an echographic
grade 3 to 4 mitral regurgitation were operated on according to Alfieri's technique. The
mean age was 64.3 ± 16.2 years. In 17 cases, there was a bileaflet prolapsed degenera-
tive valve, in 7 cases there was a pure or associated ischemic mitral regurgitation, and in
4 cases an endocarditis. The operation consisted on suturing the free margins of the pro-
lapsed segments of the two leaflets in 100% of cases. Associated procedures were Car-
pentier's ring annuloplasty in 62.4% and CABG in 14.3% of cases. After a mean of follow-
up of 7.5 months, all patient were seen at the outpatient clinic for a clinical evaluation, an
echocardiogram at rest and at peak exercise, and a cardio respiratory exercise testing
with maximal oxygen uptake (VO2 max) recording.
Results: There was no early or late death. Improvement of the NYHA class was
observed in all patients with a conversion from a mean preoperative value of 3.1 ± 1 to a
postoperative value of 1.3 ± 0.5 (p< 0.0001). Eighty-two per cent of patients have had no
residual mitral regurgitation. In all cases there was a lowering of the arterial systolic pul-
monary pressure from a mean of 45 ± 19 mmHg preoperatively to 36 ± 11 mmHg postop-
eratively (p= 0.02) and LVEF remained unchanged from 59 ± 10 to 63 ± 12 (p=0.17). The
mean transmitral gradient was 3.6 ± 1.6 at rest and increased to 8 ± 3.3mmHg during
peak exercise (p<0.0001). The mean mitral area was 2.4 ± 0.1cm2. Among the 21 inter-
pretable cardio respiratory exercise testing, 57.1% of the patients had normal exercise
tolerance (mean VO2 max >85% normal value), 33.3% patients had a moderate cardio-
genic limitation (69.8% mean VO2 max), and 9.6% of the patients had a muscular exer-
cise limitation due to exercise deconditioning.
Conclusion: According to these results, this technique seems to induce a restrictive
aspect of the repair as demonstrated by the valve area, the transvalvular gradients and
the limitation of VO2 max, but its impact on clinical status seems moderate.
1048-139 Impact of Associated Coronary Disease on Hospital 
Survival of Patients With Valvular Heart Diseases in New 
York State (1983-2000)
Phyllis G. Supino, Amanda D. Konstam, Jeffrey S. Borer, Weill Medical College of Cornell 
University, New York, NY
Background: Coronary artery disease (CAD) is an important cause of perioperative and
late mortality among patients (pts) who undergo surgery (VS) for valvular heart disease
(VHD). However, no data exist regarding recent temporal trends in CAD prevalence and
its relation to mortality in VHD; also, the benefit of bypass grafting (CABG) plus VS for
CAD+VHD is not well defined. Methods: We conducted a longitudinal analysis (1983-
2000) of records from the New York Statewide Planning and Research Cooperative Sys-
tem (SPARCS) inpatient database; each bore a principal or secondary ICD-9 code for
VHD ±CAD ±CABG. Linear regression was used to model temporal trends in CAD and
hospital death rates (MORT) among pts with and without CAD and/or CABG. Chi Square
and multivariate logistic regression analyses defined the relation of MORT to CAD,
CABG and selected clinical factors. Results: We identified 1,162,318 pts with VHD;
333,359 (33%) had associated CAD; 63,250 pts died in the hospital. In VHD pts, CAD
increased over 18 years at 1993 pts/yr (linearized rate, p<.001) and was associated with
higher MORT (25,245/383,359 [CAD, 6.6%] vs 38,005/778,959[no CAD, 4.9%] p<.001).
VS was performed in 77,564 pts; 35,974 (46%) had associated CAD and 27,670/35,974
(76.9%) of these underwent VS+CABG. This proportion did not change during the 18-
year interval (NS). Among VS pts, avg. MORT varied with CAD and CABG: no
CAD=5.8%, CAD/No CABG=8.7%, CAD/CABG=10.3%, p<.001. MORT in all subgroups
decreased similarly over time (p<.001). Independent MORT predictors in VS+CAD were
concomitant CABG(p=.007), age >65 years, female gender, non-white race, CHF, mitral
VHD, p<.001 all variables. Conclusions: CAD is frequent in pts with VHD; its prevalence
has not decreased over time. In VHD, CAD increases MORT but CABG may not blunt this
risk. Additional data must define the basis for this apparent paradox and identify optimal
treatment options for this high-risk population.
1048-140 Accuracy of Presurgical Assessment of Myxomatous 
Mitral Valve Pathology Using Real-Time Three-
Dimensional Echocardiography
Lissa Sugeng, Yan Katsnelson, Lynn Weinert, R. Parker Ward, Kirk T. Spencer, Jeanne 
M. DeCara, Victor Mor-Avi, Valluvan Jeevanandam, Roberto M. Lang, University of 
Chicago, Chicago, IL
Transesophageal echocardiography (TEE) aids in the presurgical planning of mitral valve
(MV) disease, however, multiple views are required to delineate the exact location of the
MV pathology. Although three-dimensional echocardiography (3DE) provides unique
views of the MV, previous methods have been tedious and time consuming. The availabil-
ity of real-time transthoracic imaging technology overcomes these limitations. Our goal
was to evaluate the accuracy of real-time transthoracic 3DE using a newly developed full
matrix array probe (x4, Philips) in detecting MV pathology when compared to TEE, using
surgical confirmation as a gold standard. Method. 12 patients undergoing TEE evalua-
tion prior to mitral valve surgery were studied. Real-time 3DE images of the MV were
obtained from parasternal and apical windows. Images were interpreted by a reader
blinded to the results of TEE and surgical diagnoses. Results. 10/12 patients (83%) had
adequate 3D image quality for interpretation. 3DE accurately detected abnormal MV seg-
ments in 9/10 patients, but failed to detect abnormal A1 and A3 segments of the MV in
one patient. TEE failed to correctly diagnose 2 patients. In one patient, a perforated ante-
rior leaflet was misinterpreted. In the second patient, TEE incorrectly interpreted the
extent of a P2 lesion. Conclusion. Compared with surgical findings, real-time 3DE has
diagnostic ability comparable to that of TEE in detecting abnormal MV segments, but with
an important advantage of being less invasive. 
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1067-135 Over-Expression of Fibronectin Involves Activation of 
Mitogen-Activated Protein-Kinase-Kinase of the Stress 
Activated Protein Kinase/C-Jun N-Terminal Kinase in 
Aortic Regurgitation
Sharada L. Truter, Themy F. Dumlao, Eungsuk Lee, Zhen Huang, Jeffrey S. Borer, Weill 
Medical College of Cornell University, New York, NY
Background: Experimentally and clinically, chronic aortic regurgitation (AR) causes
myocardial fibrosis with hyperproduction of fibronectin (FN) by cardiac fibroblasts (CF).
Using cultured CF, we’ve shown increased activation of c-Jun N-terminal kinase (JNK-1)
of the MAPK cascade in AR, with consistent increases in reaction products. This sug-
gests that the MEKK-MEK-JNK signaling module of MAPK could mediate increased FN
expression in AR. To test this, we assessed MEK-4 and MEK-7 activity by assaying phos-
phorylation of JNK-1 protein in NL-CF and AR-CF. Methods: MEK-4 and MEK-7 were
immunoprecipitated from lysates of CF cultures (passage 6) from 5 pairs of NL and AR
NZW rabbit hearts, then incubated for 30 min in kinase buffer containing 32P-γ-ATP with
recombinant JNK-1 protein. Samples were separated by SDS-PAGE, dried and autorad-
iographed. Relative phosphorylation of JNK-1 by MEKs was assessed by videodensitom-
etry. Results: JNK-1 phosphorylation was increased when immunopreciptated with
MEK-4 or MEK-7 [1.7: 1, p=.005, and 1.8: 1, p=.001]; the increase was seen in 5/5 AR-
CF vs NL-CF (Table); activity of both MEKs varied directly with regurgitant fraction(RF)
[r2=.7; p=.08 for MEK-4 and r2=.87; p=.05 for MEK-7]. Conclusion: Chronic severe AR
stimulates MEK-4/7 causing JNK-1 activation and increasing FN expression by AR-CF.
Though confirmation is needed by testing effects of pathway inhibitors, these results sug-
gest possible novel pharmacologic interventions to mitigate fibrosis in AR. 
